[Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency]

Insights

Cavinton improved neurological function in patients with discirculatory encephalopathy (DE). This treatment significantly reduced the risk of DE progression, transient ischemic attacks, and strokes compared to standard therapy.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Discirculatory encephalopathy (DE) is a condition affecting brain function due to impaired blood flow.
  • Effective treatment strategies for DE are crucial for improving patient outcomes and preventing neurological deficits.

Purpose of the Study:

  • To evaluate the efficacy of Cavinton as an add-on therapy for patients with discirculatory encephalopathy.
  • To assess the impact of Cavinton on neurological status, cognitive function, and the risk of cerebrovascular events in DE patients.

Main Methods:

  • A clinical study involving 138 patients with DE treated with Cavinton (30 mg/day for 90 days, twice yearly) plus basic therapy.
  • A control group of 98 patients received only basic therapy (hypotensive, antithrombotic drugs, glycine).
  • Neurological and neuropsychological assessments were conducted at baseline and at 3, 6, and 12 months.

Main Results:

  • Patients receiving Cavinton showed significant improvement in neurological syndromes compared to the control group over 12 months.
  • Cavinton treatment led to a substantial reduction in the risk of DE progression (relative risk 0.01).
  • The risk of transient ischemic attacks and strokes was significantly decreased in the Cavinton group (relative risk 0.14).

Conclusions:

  • Complex therapy including Cavinton is effective in managing discirculatory encephalopathy.
  • Cavinton demonstrates a significant protective effect against the progression of DE and cerebrovascular events like strokes.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.